GoodRx Holdings, Inc.

NasdaqGS:GDRX Stock Report

Market Cap: US$2.9b

GoodRx Holdings Management

Management criteria checks 2/4

GoodRx Holdings' CEO is Scott Wagner, appointed in Apr 2023, has a tenure of 1.08 years. total yearly compensation is $10.14M, comprised of 5% salary and 95% bonuses, including company stock and options. directly owns 0.049% of the company’s shares, worth $1.39M. The average tenure of the management team and the board of directors is 3 years and 8.3 years respectively.

Key information

Scott Wagner

Chief executive officer

US$10.1m

Total compensation

CEO salary percentage5.0%
CEO tenure1.1yrs
CEO ownership0.05%
Management average tenure3yrs
Board average tenure8.3yrs

Recent management updates

Recent updates

GoodRx Holdings: Large TAM Continues To Support Growth

Mar 20

GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Mar 07
GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Is GoodRx Holdings, Inc. (NASDAQ:GDRX) Trading At A 24% Discount?

Mar 01
Is GoodRx Holdings, Inc. (NASDAQ:GDRX) Trading At A 24% Discount?

GoodRx Holdings (NASDAQ:GDRX) Has A Rock Solid Balance Sheet

Feb 12
GoodRx Holdings (NASDAQ:GDRX) Has A Rock Solid Balance Sheet

GoodRx: Cost Saving Is A Strong Value Proposition To Consumers

Jan 23

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Jan 22
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

GoodRx Stock Spikes After Receiving A Strong Dose Of Performance

Jan 11

What Is GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Share Price Doing?

Dec 02
What Is GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Share Price Doing?

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Sep 12
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

An Intrinsic Calculation For GoodRx Holdings, Inc. (NASDAQ:GDRX) Suggests It's 41% Undervalued

Jul 14
An Intrinsic Calculation For GoodRx Holdings, Inc. (NASDAQ:GDRX) Suggests It's 41% Undervalued

GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

May 27
GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

Some Confidence Is Lacking In GoodRx Holdings, Inc. (NASDAQ:GDRX) As Shares Slide 27%

May 05
Some Confidence Is Lacking In GoodRx Holdings, Inc. (NASDAQ:GDRX) As Shares Slide 27%

Investors Give GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares A 27% Hiding

May 05
Investors Give GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares A 27% Hiding

Is There An Opportunity With GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 45% Undervaluation?

Mar 23
Is There An Opportunity With GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 45% Undervaluation?

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Feb 07
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

GoodRx Holdings (NASDAQ:GDRX) Could Be Struggling To Allocate Capital

Nov 02
GoodRx Holdings (NASDAQ:GDRX) Could Be Struggling To Allocate Capital

GoodRx laying off 140 employees, 16% of workforce

Aug 31

GoodRx: Trending Positive, But Not A Buy Yet

Aug 25

GoodRx: Unexpected Short Squeeze As Grocer Issue Resolved

Aug 09

GoodRx: Unexpected Wrench Pushes Me To The Sidelines

Jul 25

Here's What's Concerning About GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital

Jul 20
Here's What's Concerning About GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital

GoodRx: Guidance Gets Worse, Stay Clear

May 19

GoodRx: Time To Buy The Dip

Apr 23

Returns On Capital Signal Tricky Times Ahead For GoodRx Holdings (NASDAQ:GDRX)

Apr 19
Returns On Capital Signal Tricky Times Ahead For GoodRx Holdings (NASDAQ:GDRX)

CEO Compensation Analysis

How has Scott Wagner's remuneration changed compared to GoodRx Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-US$7m

Dec 31 2023US$10mUS$512k

-US$9m

Compensation vs Market: Scott's total compensation ($USD10.14M) is above average for companies of similar size in the US market ($USD6.67M).

Compensation vs Earnings: Insufficient data to compare Scott's compensation with company performance.


CEO

Scott Wagner (52 yo)

1.1yrs

Tenure

US$10,144,526

Compensation

Mr. Scott W. Wagner serves as Interim Chief Executive Officer at GoodRx Holdings, Inc. since April 25, 2023 and serves as its Principal Operating Officer since February 15, 2024. He serves as Head of Strat...


Leadership Team

NamePositionTenureCompensationOwnership
Trevor Bezdek
Co-founder & Chairman of the Board12.7yrsUS$811.53k1.37%
$ 39.1m
Scott Wagner
Interim CEO & Principal Operating Officer1.1yrsUS$10.14m0.049%
$ 1.4m
Douglas Hirsch
Co-founder12.7yrsUS$784.86k1.37%
$ 39.1m
Karsten Voermann
Chief Financial Officer4.2yrsUS$902.24k0.057%
$ 1.6m
Romin Nabiey
Chief Accounting Officer2.1yrsUS$2.58m0.031%
$ 895.5k
Bansi Nagji
President of Healthcare3.9yrsUS$4.91m0.066%
$ 1.9m
Mike Walsh
President & Executive VP of Prescription Marketplaceless than a yearno datano data
Whitney Notaro
Vice President of Investor Relationsno datano datano data
Gracye Cheng
General Counsel & Secretaryno datano datano data
Andrew Slutsky
Chief Marketing Officerless than a yearUS$864.80k0%
$ 0
Vina Leite
Chief People Officer2yrsno datano data
Justin Fengler
Senior Vice President of Corporate Strategy & Business Operations8.3yrsno datano data

3.0yrs

Average Tenure

52yo

Average Age

Experienced Management: GDRX's management team is considered experienced (3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Trevor Bezdek
Co-founder & Chairman of the Board12.7yrsUS$811.53k1.37%
$ 39.1m
Douglas Hirsch
Co-founder12.7yrsUS$784.86k1.37%
$ 39.1m
Gregory Mondre
Independent Director5.6yrsno datano data
Dipanjan Deb
Independent Director8.6yrsno datano data
Agnes Rey-Giraud
Independent Director7.9yrsUS$269.53k0.069%
$ 2.0m
Julie M. Bradley
Independent Director3.8yrsUS$272.53k0.015%
$ 426.6k
Christopher Adams
Independent Director8.6yrsno datano data
Kelly Kennedy
Independent Directorless than a yearUS$448.63kno data

8.3yrs

Average Tenure

53yo

Average Age

Experienced Board: GDRX's board of directors are considered experienced (8.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.